<DOC>
	<DOCNO>NCT02218424</DOCNO>
	<brief_summary>This study double-blind randomize control trial use intravenous magnesium versus placebo determine systemic magnesium decrease postoperative pain pediatric patient undergo tonsillectomy . Participants one two arm . Those Arm 1 receive magnesium ( 30 mg/kg bolus follow 10mg/kg/hr infusion ) Arm 2 receive equal volume normal saline bolus follow infusion ( placebo ) . The primary objective determine systemic magnesium decrease postoperative pain patient undergoing tonsillectomy . The secondary objective determine systemic magnesium administration associate decrease opioid-related side effect , decrease incidence emergence delirium , improve postoperative functional recovery . The study hypothesis use intravenous magnesium decrease postoperative pain , decrease opioid-related side effect , decrease incidence emergence delirium , improve functional recovery patient undergo tonsillectomy .</brief_summary>
	<brief_title>Magnesium v Placebo Tonsillectomy</brief_title>
	<detailed_description />
	<criteria>Patients age 410 year old undergoing tonsillectomy single surgeon care participate surgeon American Society Anesthesiology ( ASA ) patient classification IIII Physical developmental delay Psychiatric illness Current use sedative anticonvulsant medication Preexisting renal disease Preexisting cardiovascular disease Regular use analgesic medication Having procedures addition tonsillectomy ( however , patient undergo adenoidectomy tonsillectomy include study )</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>